News
PMCPA News
Press releases appear below, filter by date.
PMCPA Annual Report 2022 and 2023
Press release: 09 September 2024
New Appointments at the PMCPA
Press release: 09 September 2024
Novartis, Pfizer, Otsuka and Novo Nordisk named in advertisements for breaches of the ABPI Code
Press release: 05 July 2024
ABPI Code of Practice training
Press release: 02 July 2024
New webform for companies to submit nominated signatories
Press release: 20 June 2024
Consultation on proposed changes to the 2021 ABPI Code and PMCPA Constitution and Procedure - Update
Press release: 13 June 2024
Consultation on proposed changes to the 2021 ABPI Code and PMCPA Constitution and Procedure - Update
Teva and Daiichi Sankyo named in advertisements for breaches of the ABPI Code
Press release: 27 March 2024
Teva and Daiichi Sankyo named in advertisements for breaches of the ABPI Code
Vacancy for the position of Deputy Director, PMCPA
Press release: 22 March 2024
Vacancy for the position of Deputy Director, PMCPA
ABPI Code Of Practice training
Press release: 17 January 2024
ABPI Code Of Practice training
Consultation on the proposed changes to the 2021 ABPI Code and the Constitution and Procedure
Press release: 13 December 2023
Consultation on the proposed changes to the 2021 ABPI Code and the Constitution and Procedure
New vacancies at the PMCPA
Press release: 20 October 2023
New vacancies at the PMCPA
Novartis, Roche, Croma Pharma, Daiichi Sankyo, AstraZeneca and AbbVie named in advertisements for breaches of the ABPI Code
Press release: 18 October 2023
Novartis, Roche, Croma Pharma, Daiichi Sankyo, AstraZeneca and AbbVie named in advertisements for breaches of the ABPI Code